Glucokinase-activating GCKR polymorphisms increase plasma levels of triglycerides and free fatty acids, but do not elevate cardiovascular risk in the Ludwigshafen Risk and Cardiovascular Health Study.

Source:http://linkedlifedata.com/resource/pubmed/id/20352598

Download in:

View as

General Info

PMID
20352598